Astrid Drenckhan
-
- Chemokine receptors and signaling 3
- Cancer Cells and Metastasis 2
-
- Cancer, Hypoxia, and Metabolism 4
-
- Glycosylation and Glycoproteins Research 3
- Enzyme function and inhibition 2
-
- Neuroblastoma Research and Treatments 3
-
- Lung Cancer Treatments and Mutations 2
-
- Tumors and Oncological Cases 1
- Co-authors
- Jakob R. IzbickiStephanie J. GrosThorsten DohrmannJussuf T. KaifiFlorian EwaldUta ReicheltManfred JückerKonrad Reinshagen
- Cited by
- ImmunologyOncologyNephrology
- Journals
- PLoS ONE (2 papers)Cancer Research (1 paper)Journal of the American Society of Nephrology (1 paper)
- Partner nations
- GermanySwitzerlandItaly
In The Last Decade
Astrid Drenckhan
13 papers receiving 359 citations
Peers
Comparison fields: 5 of 59
- Immunology 106
- Oncology 130
- Nephrology 29
- Cancer Research 56
- Molecular Biology 228
Countries citing papers authored by Astrid Drenckhan
This map shows the geographic impact of Astrid Drenckhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Drenckhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Drenckhan more than expected).
Fields of papers citing papers by Astrid Drenckhan
This network shows the impact of papers produced by Astrid Drenckhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Drenckhan. The network helps show where Astrid Drenckhan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Astrid Drenckhan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 5 | |
| 2 | 2020 | 1 | |
| 3 | 2018 | 17 | |
| 4 | 2015 | 22 | |
| 5 | 2015 | 12 | |
| 6 | 2015 | 90 | |
| 7 | 2014 | 41 | |
| 8 | 2014 | 6 | |
| 9 | 2013 | 19 | |
| 10 | CXCR4/SDF-1α-mediated chemotaxis in an in vivo model of metastatic esophageal carcinoma. | 2013 | 14 |
| 11 | 2012 | 39 | |
| 12 | 2012 | 38 | |
| 13 | 2011 | 57 | |
| 14 | 2011 | 1 |
About Astrid Drenckhan
Astrid Drenckhan is a scholar working on Oncology, Cancer Research and Neurology, having authored 14 papers that have together received 362 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Glycosylation and Glycoproteins Research (3 papers), Neuroblastoma Research and Treatments (3 papers), Chemokine receptors and signaling (3 papers), Enzyme function and inhibition (2 papers), Cancer Cells and Metastasis (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Tumors and Oncological Cases (1 paper). The work is most often cited by research in Immunology (106 citations), Oncology (130 citations) and Nephrology (29 citations). Astrid Drenckhan has collaborated with scholars based in Germany, Switzerland and Italy. Frequent co-authors include Jakob R. Izbicki, Stephanie J. Gros, Thorsten Dohrmann, Jussuf T. Kaifi, Florian Ewald, Uta Reichelt, Manfred Jücker, Konrad Reinshagen, Claudiu T. Supuran and Stefan Holland‐Cunz. Their work appears in journals such as PLoS ONE, Cancer Research and Journal of the American Society of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.